project id: TCGA-HNSC; case submitter id: TCGA-CN-A63V; source center: 23; state: released; a260 a280 ratio: 1.95; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 7.0; age at index: 59; days to birth: -21734; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1952; age at diagnosis: 21734; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IVA; ajcc clinical t: T4; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 679.0; icd 10 code: C06.0; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cheek mucosa; synchronous malignancy: No; tissue or organ of origin: Cheek mucosa; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: No; cigarettes per day: 3.287671232876712; pack years smoked: 60.0; is ffpe: false; composition: Not Reported; days to collection: 470; days to sample procurement: 0; initial weight: 750.0; portion submitter id: TCGA-CN-A63V-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 40.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;